Pennwell web 200 200

Keller Labs introduces EMA First Step

June 20, 2011
Product is a patient-friendly, 90-day trial oral appliance for the noninvasive treatment of snoring and obstructive sleep apnea.
New EMA First Step from Keller Laboratories is a simple, patient-friendly, 90-day trial oral appliance for the noninvasive treatment of snoring and obstructive sleep apnea. To read more about Keller Labs, go to Keller Labs.The primary treatment mechanism of opening the bite and gently moving the mandible forward is achieved using interchangeable elastic straps that offer varying degrees of mandibular advancement. By holding the mandible forward, the EMA First Step maintains a clear airway to reduce snoring and improve breathing. The EMA First Step’s design eliminates common barriers to case acceptance including treatment cost, uncertainty of effectiveness, and patient compliance. The appliance is available to be made in an office for $69 or Keller can fabricate it for $89. The EMA First Step is FDA-approved, and patients will have the 90-day trial period to recognize the benefits of improved sleep and decide if a long-term therapeutic device is right for them. For the EMA First Step video tutorial, go to the video library at www.kellerlab.com.For more information, please call (800) 325-3056 or visit www.kellerlab.com.To comment on this product, go to community.pennwelldentalgroup.com/.